Clinical Evidence

 Definitive Closure.

The CELT ACD Vascular Closure Device is manufactured by Vasorum Ltd and Veryan supports the sales activity of the device in the United States.

For more information visit


Clinical Evidence


A Multicenter Randomized Trial Comparing the Effectiveness and Safety of a Novel Vascular Closure Device to Manual Compression in Anticoagulated Patients Undergoing Percutaneous Transfemoral Procedures: The CELT ACD Trial

Short post-procedural bedrest using vascular closure device in the femoral artery: Is it possible?

Celt ACD, A Novel Stainless Steel Femoral Artery Closure Device, Reduces Time to Hemostasis, Patient Discomfort and Late Bruising Compared with Angio-seal™

First Clinical Experience With Celt ACD: A Femoral Arterial Puncture Closure Device

Prospective Evaluation of the CELT Arterial Closure Device in an Outpatient Based Catheterization Laboratory